NCT05811247: An ongoing trial by Apnimed
This trial is ongoing. It must report results 3 weeks, 6 days ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05811247 |
|---|---|
| Title | Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of Aroxybutynin/Atomoxetine (AD109) to Placebo in Obstructive Sleep Apnea (LunAIRo Study) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 28, 2023 |
| Completion date | May 7, 2025 |
| Required reporting date | May 7, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | None |